News
A single cell.
A global business worth billions.
A trade that can bring rewards—or human costs that cannot be measured...
Updates to South African research ethics guidelines which recognize significant potential for treating genetic diseases through heritable human genome editing...
A new book, Predatory Data, by Anita Say Chan, takes on the
throughline from the rise of 20th-century eugenics to Silicon...
The integration of artificial intelligence (AI) in the biotech industry seems boundless. Its combination with CRISPR could be the one...
Since its discovery in the early 1940s, epigenetics has been established as a key driver of human development, health, aging...
Lucy Landman was born with a very rare genetic disorder that causes severe intellectual disability, weak muscles and seizures...
As more people access fertility services in their journeys to becoming parents, Toronto Metropolitan University professor Katie Hammond says the...
23andMe, a major company providing direct-to-consumer genetic testing, has been struggling financially since late 2023. In September 2024, the company’s...
FOR YEARS NOW, aspiring parents have been designing their children. Screening embryos for disease-causing genes during IVF, selecting their future baby’s...